Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

This study is testing a nutritional supplement called BRUDYGLAUCO — which contains DHA (an omega-3 fatty acid) and citicoline — to see if it can slow the loss of vision in people with glaucoma. Glaucoma is a disease where the optic nerve gradually gets damaged, leading to vision loss. **You may be eligible if...** - You are 50–75 years old - You have been diagnosed with chronic glaucoma (any type) in at least one eye - Your glaucoma has caused measurable damage to the optic nerve and your visual field, confirmed by imaging - You have had at least 4 reliable visual field tests before the study **You may NOT be eligible if...** - You have taken any vitamins or nutritional supplements in the past month - You have neurological diseases, severe retinal diseases, or advanced cataracts that could affect vision testing - You take a medication called Lyrica (pregabalin), which affects visual fields - You have had eye surgery or laser treatment in the last 3 months, or have it planned - You are allergic to aspirin (there is a cross-reaction risk with citicoline) - Your visual field loss is either very mild or very severe (outside the study range) Talk to your doctor to see if this trial is right for you.